Traditional Chinese medicine for treating leukemia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of traditional Chinese medicine and Hedyotis diffusa can be used in drug combinations, anti-tumor drugs, pharmaceutical formulations, etc., and can solve problems such as adverse reactions, harm to health, and unsatisfactory efficacy.
Active Publication Date: 2013-09-04
袁军清
View PDF4 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] At present, the incidence of this disease is on the rise, seriously endangering people's health and even life. Clinically, radiotherapy
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0024] A traditional Chinese medicine for treating leukemia includes the following components by weight: 160g buffalo horn, 160g Qingdai, 160g cortex Moutan, 120g Scutellaria baicalensis, 160g Hedyotis diffusa, 160g Astragalus membranaceus, 60g Coptis chinensis, 80g Rehmannia glutinosa, and 20g American ginseng. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
Embodiment 2
[0026] A traditional Chinese medicine for treating leukemia comprises the following components by weight: 150g buffalo horn, 170g Qingdai, 150g cortex Moutan, 130g Scutellaria baicalensis, 150g Hedyotis diffusa, 170g Astragalus, 58g Coptis Rhizoma, 82g Rehmannia glutinosa, 18g American ginseng, 10g honeysuckle, fishy Grass 20g, Arborvitae leaves 10g, Artemisia argyi 8g. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
Embodiment 3
[0028] A traditional Chinese medicine for treating leukemia comprises the following components by weight: 170g of buffalo horn, 150g of Qingdai, 170g of Moutan cortex, 110g of Scutellaria baicalensis, 170g of Hedyotis diffusa, 150g of Radix Astragali, 62g of Coptidis Rhizoma, 78g of Rehmannia glutinosa, 22g of American ginseng, 15g of honeysuckle, fishy Grass 30g, Arborvitae leaves 12g, Artemisia argyi 3g. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine for treating leukemia. The traditional Chinese medicine comprises the components as follows: 150-170 g of buffalo horns, 150-170 g of indigo naturalis, 150-170 g of moutan bark, 110-130 g of scutellaria baicalensis, 150-170 g of oldenlandia diffusa, 150-170 g of astragalus membranaceus, 58-62 g of coptis chinensis, 78-82 g of rehmannia and 18-22 g of American ginseng. A formula of the traditional Chinese medicine also can comprise the components as follows: 10-15 g of honeysuckles, 15-30 g of houttuynia cordata, 6-12 g of cacumen biotae and 3-15 g of folium artemisiae argyi. All the components are combined, functions of benefiting qi and nourishing blood, detoxifying and clearing marrow, cooling and activating blood and enabling juvenile cells to be subjected to differentiation and apoptosis are realized. The traditional Chinese medicine is used for treating poison stasis incubation, a qi-blood deficiency syndrome and various types of acute and chronic leukemia. By means of clinical application for many years, the effect is clear, and the toxic and side effects are small.
Description
technical field [0001] The invention relates to a traditional Chinese medicine for treating leukemia. Background technique [0002] Leukemia, commonly known as blood cancer, is a malignant clonal disease of hematopoietic stem cells. Leukemia cells in its clones have uncontrolled proliferation, differentiation disorders, apoptosis, and stagnation at different stages of cell development. Leukemia cells in bone marrow and other tissues A large amount of hyperplasia accumulates and infiltrates other tissues and organs, thereby inhibiting normal hematopoiesis. Clinically, anemia, fever, infection, hemorrhage, hepatosplenomegaly, etc. are the main manifestations. The quantity and quality of white blood cells in peripheral blood are abnormal, and immature cells often appear. [0003] Types: (1) According to the degree of maturity of leukemia cells and the natural course of the disease, leukemia is divided into two categories: acute and chronic. AL cell differentiation stagnates at...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more